NDC80 and cancer: The overexpression of NDC80 has been identified to be an oncogenic biomarker with poor prognosis in several cancers, including gastric and ovarian cancer, and osteosarcoma (Mo et al., 2013; Qu et al., 2014; Xu et al., 2017).